HEIDI MATTISON: Open Payments
NPI 1043667520 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 24 payments from 10 companies in 2025. Trend: 2023 $66 · 2024 $185 · 2025 $523
Food & beverage: $523
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $91 |
| Vanda Pharmaceuticals Inc. | 3 | $77 |
| Neurocrine BioSciences, Inc. | 3 | $76 |
| E.R. Squibb & Sons, L.L.C. | 3 | $59 |
| ABBVIE INC. | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| Boston Scientific Corporation | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Corium, LLC | 2 | $15 |
Products named: FANAPT, INGREZZA, INVEGA SUSTENNA, COBENFY, VRAYLAR, WaveWriter Alpha Prime 16, AUSTEDO XR, SPRAVATO.
Industry payments across FL — which companies pay providers there.
